CASP3 and B-cell chronic lymphocytic leukemia: Immunofluorescence staining revealed a significantly higher number of Caspase 3+ CLL B cells (white arrows) after AP‐1 inhibition (right panel) compared to the control (left panel) (Figure 6E).